Home | MyCME | All CME | Blog | Psychlopedia

Top 10 CME Activities in the Past Week

  1. Recognition and Treatment of Pediatric Bipolar Disorder

    Robert L. Findling (Chair) et al

    Do you find the diagnosis and treatment of pediatric bipolar disorder challenging? Read this CME supplement to learn about the phenomenology and differential diagnosis of bipolar disorders in children and adolescents as well as evidence-based pharmacologic and psychotherapeutic interventions. With effective treatment and the support of their families, young patients with bipolar disorder can learn to manage the illness and become independent, healthy adults.

  2. Enhancing Approaches to the Identification and Management of Pseudobulbar Affect

    David W. Crumpacker

    Pseudobulbar affect has been unrecognized and untreated for too long. Engage in this activity and watch its brief videos to learn about this embarrassing, socially limiting condition so you can better help your patients.

  3. Challenges in the Recognition and Treatment of Binge-Eating Disorder

    Susan G. Kornstein (Chair) et al

    Binge-eating disorder (BED) is the most common eating disorder but is often overlooked. Consequences of binge eating may include psychological distress, obesity, and metabolic symptoms. Read this CME Supplement to better recognize the signs and symptoms of BED and to provide appropriate evidence-based care.

  4. The Role of Insomnia in Depression and Anxiety: Its Impact on Functioning, Treatment, and Outcomes

    Andrew Cutler

    The case of 42-year-old Mrs C illustrates the common combination of anxious depression and sleep problems. In this activity, learn about the relationship between these disorders and find effective strategies to treat insomnia with depression and anxiety.

  5. Recognizing and Managing Insomnia in Primary Care and Specialty Settings

    Krystal and Sorscher

    Watch this webcast to see two patient cases with different sleep difficulties. Listen as the faculty discuss these cases and give evaluation tools and treatment strategies that will help you manage patients with sleep problems in your own practice.

  6. Managing Medical Comorbidities in Patients With Depression to Improve Overall Prognosis

    Michael E. Thase

    What additional precautions should be taken when a patient presents with symptoms of depression as well as medical comorbidities? Consider the options as you review this new Case and Comment activity about Tony, a 64-year-old man whose treatment-resistant depression is more difficult to manage due to medical conditions.

  7. A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications

    Wilkinson et al

    Marijuana has been approved in many US states to treat a number of psychiatric conditions, including posttraumatic stress disorder, agitation in Alzheimer’s disease, and Tourette’s disorder. But what is the strength of evidence for the efficacy of marijuana and other cannabinoids for these psychiatric indications? Learn more by reading this CME journal article.

  8. Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission

    Rakesh Jain

    Most patients with major depressive disorder will not achieve remission with initial treatment. Strategies to increase the likelihood of achieving remission include regularly measuring response, assessing adverse effects and adherence, addressing non-mood symptoms, and knowing when to switch or augment antidepressants. In this CME Health Spectrum activity, follow 2 patient cases that illustrate these topics.

  9. Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial

    Sakurai et al

    When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out whether increasing the dose provides any greater benefit than waiting longer for patients to respond to the lower dose.

  10. Measuring and Managing Cognitive Impairment in Schizophrenia

    S. Charles Schulz (Chair), et al

    Cognitive impairment is present in almost all patients with schizophrenia, yet it often receives less clinical attention than positive and negative symptoms. Read this supplement to help identify, monitor, and manage these symptoms in your patients.